Showing 34,982 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

The search for a cure

‘Something remarkable has happened’: Cancer treatments bolster evidence of a natural HIV cure

Editor's pick
Science Magazine
18 July 2025
Injectable & long-acting PrEP

Lenacapavir and cabotegravir PrEP supported for use in pregnancy and breastfeeding

News
18 July 2025

IAS 2025: Monthly oral PrEP pill advances to phase III trials, 18 July 2025

July 2025
Injectable & long-acting HIV treatment

Injectable HIV treatment works for people with poor HIV control in Africa

News
17 July 2025
Ageing & HIV

The Sussex Beacon to become UK’S first LGBTQ+ hospice with HIV specialism

Editor's pick
17 July 2025
Treatment simplification strategies

Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns

News
17 July 2025
Finance & funding

Scaling back PEPFAR will leave 700,000 without PrEP and cause 6700 new HIV infections within a year

News
17 July 2025
Weight gain & lipodystrophy

Treatment changes do not reduce weight in people with HIV

News
17 July 2025
Injectable & long-acting PrEP

Once-monthly oral PrEP moves into late-stage trials

News
17 July 2025
PrEP science

HIV PrEP Study Finds Modest Bone Loss on FTC/TDF Compared to Cabotegravir

Editor's pick
TheBodyPro
16 July 2025
HIV treatment for children & young people

Childhoods at Risk: 2025 HIV Data Reveal an Urgent Crisis

Editor's pick
Partnership for Maternal Newborn and Child Health
16 July 2025
Transgender people

What To Know About Prescribing Gender-Affirming Hormone Therapy With HIV Treatment

Editor's pick
TheBodyPro
16 July 2025
Injectable & long-acting PrEP

WHO recommends injectable lenacapavir for HIV prevention

Editor's pick
World Health Organization
16 July 2025
Access to healthcare

US: The Coming HIV Care Crisis

Editor's pick
HIV-HCV Co-Infection Watch
16 July 2025
Harm reduction

Syringe Programs Boost Hepatitis C Treatment for People Who Inject Drugs

Editor's pick
POZ
16 July 2025
Injectable & long-acting PrEP

Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill

Editor's pick
Merck press release
16 July 2025
HIV & criminal law

New global data reveals rising HIV criminalisation amid stalling legal reforms

Editor's pick
HIV Justice Network
16 July 2025
Injectable & long-acting PrEP

New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention

Editor's pick
ITPC Global
16 July 2025
Government, leadership & policy

Francois Venter | Slow motion denialism: South Africa's leaders are allowing the HIV response to collapse

Editor's pick
Spotlight
16 July 2025
Travel

Global study reveals 50 countries still enforce HIV-related travel restrictions

Editor's pick
HIV Justice Network
16 July 2025
HIV vaccine & cure research

Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect

News
16 July 2025
Sexually transmitted infections prevention

Resistance is a growing concern amid rising use of doxyPEP

News
16 July 2025

IAS 2025: HIV funding crisis the focus of IAS 2025, 16 July 2025

July 2025
Finance & funding

“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025

News
16 July 2025